ADO anteotech ltd

0.00%

1.4¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39

First 39 Last

Share
Profile

Follow
Bottsy13

3,556 Posts.

460

24/04/24

10:50

Post #: 73492929
Share

Originally posted by captainblood: ↑

great post PF, just some extra thoughts

- "The goal of this work is inclusion of Anteo X in EV1’s upcoming “design freeze” towards the end of 2024."

if ev1 is merc,BMW, Porsche,audi or the like and they are doing a new battery design, I would imagine that an AnteoX improved anode mightn't be the only component improvement that they are planning to make. work on the cathode, separator etc would probably be worked on as well.

even though the design freeze happens at the end of 2024, I would suspect that the individual improvements would be locked in and ev1 would do several months of combined components battery testing before a design freeze is finalised. so commercial agreements could be signed before that deadline

- we have only heard how we are progressing with ev1 before yesterday. good to hear about ev2, giga factory and the 2 consumer electronics companies.

several mentioned as being interested in our ultra high silicon anodes. even though most of the timelines go into next year, this is where David's mentioning several times about jv's will come into play IMO. that means the companies and plans being announced publicly unlike ev1. IMO... we won't be making our ultra high silicon anodes, so jv deals or similar arrangement will be the way forward IMO

- as I posted yesterday

"In parallel, the Company is also pursuing funding from non-dilutive sources, with applications being progressed during the Quarter."

APPLICATIONS

- development in our ultra high silicon anode seems to be stuck around 650+ cycles for a while. hope Manuel's presentation next month on the 16th shows more advancement

- "Anteo X production facility construction complete – first Anteo X production scheduled in April 2024" there is only 7 days of April left

"The Company expects the facility to enable further Anteo X development as well as initial commercialisation activities commencing in Q4 FY2024."

- SIOI. seems like a chance for short term revenues coming

IMO a very detailed excellent quarterly. but the company needs some announcements to turn around company sentiment. GLTAH.....

Expand

I have to agree captain.

The EV company will want to have everything locked in at that point ready to go to the board.

You would think the company would have some sort of agreement in place well before. You wouldnt want to go to the board with the design, have it approved but then have discussions with a key component fall through ornbe delay. That's just my thoughts as it would be embarrassing for them.

ADO Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 39 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $37.87M

Open	High	Low	Value	Volume
1.5¢	1.5¢	1.4¢	$12.64K	886.6K

Buyers (Bids)

No.	Vol.	Price($)
7	1057201	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	4211074	13

View Market Depth

No.	Vol.	Price($)
7	1057201	0.014
6	1159222	0.013
6	2041372	0.012
7	2658674	0.011
7	3309000	0.010

Price($)	Vol.	No.
0.015	3776793	10
0.016	1427582	2
0.017	218695	4
0.018	1186369	5
0.019	1117333	8

Last trade - 16.10pm 27/06/2025 (20 minute delay)

ADO (ASX) Chart

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-39

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News